Wuhan Keqian Biology Co (SHSE:688526) Scaled Net Operating Assets : 0.64 (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Wuhan Keqian Biology Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Wuhan Keqian Biology Co's operating assets for the quarter that ended in Sep. 2024 was ¥3,366.2 Mil. Wuhan Keqian Biology Co's operating liabilities for the quarter that ended in Sep. 2024 was ¥509.6 Mil. Wuhan Keqian Biology Co's Total Assets for the quarter that ended in Jun. 2024 was ¥4,470.9 Mil. Therefore, Wuhan Keqian Biology Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.64.

Wuhan Keqian Biology Co Scaled Net Operating Assets Historical Data

The historical data trend for Wuhan Keqian Biology Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Keqian Biology Co Scaled Net Operating Assets Chart

Wuhan Keqian Biology Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.36

0.43

0.79

0.71

0.64

Wuhan Keqian Biology Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.55	0.59	0.56	0.58	0.64

Competitive Comparison of Wuhan Keqian Biology Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Wuhan Keqian Biology Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuhan Keqian Biology Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Wuhan Keqian Biology Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Wuhan Keqian Biology Co's Scaled Net Operating Assets falls into.

Wuhan Keqian Biology Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Wuhan Keqian Biology Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(3344.468	-	540.083)	/	4390.642
=	0.64

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	4671.249	-	1326.781
=	3344.468

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	833.592	-	5.745	-	287.764
=	540.083

Wuhan Keqian Biology Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Jun. 2024 )
=	(3366.168	-	509.571)	/	4470.856
=	0.64

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	4431.965	-	1065.797
=	3366.168

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	573.293	-	5.443	-	58.279
=	509.571

Wuhan Keqian Biology Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Wuhan Keqian Biology Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuhan Keqian Biology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wuhan Keqian Biology Co Ltd (SHSE:688526) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 419, Gaoxin 2nd Road, Donghu New Technology Development Zone, Hubei Province, Wuhan, CHN, 430073

Website

http://www.kqbio.com

Wuhan Keqian Biology Co Ltd is engaged in research and development, production, sales and animal epidemic prevention technical services of veterinary biological products. The company's products include Combination plan; Vaccine for swine; Poultry vaccine; Pet vaccine; and Diagnostic reagent.

Executives

Ye Zhang Fa	Supervisors
Hao Gen Xi	Core technical personnel
Zhang Hua Wei	Core technical personnel
Zhou Ming Guang	Core technical personnel
Zou Tian Tian	senior management
Xu Gao Yuan	Director
Chen Guan Ping	Director

Wuhan Keqian Biology Co Headlines

No Headlines